(Montreal) Finance Minister Chrystia Freeland presented Saturday in Toronto the first stage of the national drug insurance plan, which will include coverage of contraceptives and prescription diabetes medications.
Minister Freeland held a press conference at a downtown pharmacy in the Queen City, alongside Ya’ara Saks, Minister of Mental Health and Addictions.
The details revealed Saturday follow the tabling of a bill last February on a national and universal drug insurance plan, resulting from an agreement with the New Democratic Party (NDP). The government had previously announced that it would provide universal, single-payer coverage for a range of contraceptives and diabetes medications through agreements with the provinces.
“Women should be able to make their own choices when it comes to their health and their bodies. Our plan to provide free of charge for the most widely used contraceptives, such as the birth control pill and the IUD, and even emergency oral contraceptives, will give nine million Canadian women the freedom of choice,” Minister Freeland said in a press release.
This freedom should not have a price.
Chrystia Freeland, Minister of Finance, in a press release
The drug insurance program will be included in the federal government’s 2024 budget, which will be presented on April 16.
In addition to the initial list of drugs, the bill establishes several next steps and deadlines intended to push the government toward a broader drug insurance plan.
In his press briefing on February 29, the federal Minister of Health, Mark Holland, indicated that Bill C-64 provided that funding is conditional on the signing of bilateral agreements that expand the existing coverage of a public drug insurance plan.
The government also announced that it did not intend to pay full compensation if provinces or territories decided to withdraw from the national drug insurance plan.
The Quebec government has already indicated that it will defend its areas of jurisdiction provided for by the Constitution.
With information from Michel Saba, The Canadian Press